Stem Cells http://www.stemcellsportal.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thomas, R.
Right arrow Articles by Lipsky, P. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thomas, R.
Right arrow Articles by Lipsky, P. E.
Stem Cells, Vol. 14, No. 2, 196-206, March 1996
© 1996 AlphaMed Press


CONCISE REVIEW

Dendritic Cells: Origin and Differentiation

Ranjeny Thomasa, Peter E. Lipskyb

a University of Queensland, Department of Medicine, Princess Alexandra Hospital, Brisbane, Queensland, Australia;
b Division of Rheumatology, University of Texas Southwestern Medical Center, Dallas, Texas, USA

Key Words. Dendritic cells • Differentiation • Rheumatoid arthritis • Stem cell • Precursor • Antigen • Endocytosis • Lineage

Dr. R. Thomas, University of Queensland, Department of Medicine, Princess Alexandra Hospital, Brisbane, QLD 4102, Australia.

Dendritic cells (DC) are bone marrow-derived cells that are specialized to take up, process and present antigen, and have the capacity to stimulate resting T cells in the primary immune response. DC are a unique population that is likely to derive from a myeloid precursor cell. DC differentiation from bone marrow precursors is enhanced by the cytokines GM-CSF and tumor necrosis factor-{alpha}. In contrast, it has been proposed that thymic DC and T cells arise from a common stem cell, and that these DC play a specific role in the negative selection of thymic T cells. A number of post-bone marrow differentiation stages can be defined phenotypically and functionally. Undifferentiated DC have very active endocytic pathways, including receptor-mediated endocytosis involving a mannose/ß glucan receptor, and macropinocytosis of soluble antigen. In contrast, later stages of maturation are associated with a decreased ability to take up and process antigen, and increasing expression of major histocompatibility complex, adhesion and costimulatory molecules. Finally, activation of DC for full antigen-presenting cell function can be identified by the expression of CD28 ligands. The inflammatory site in rheumatoid arthritis is a human model of DC differentiation in response to a chronic antigenic stimulus. The features of this DC model are discussed.




This article has been cited by other articles:


Home page
Int ImmunolHome page
T. Nikolic, M. F. T. R. d. Bruijn, M. B. Lutz, and P. J. M. Leenen
Developmental stages of myeloid dendritic cells in mouse bone marrow
Int. Immunol., April 1, 2003; 15(4): 515 - 524.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
S. C. Dixon, K. B. Knopf, and W. D. Figg
The Control of Prostate-Specific Antigen Expression and Gene Regulation by Pharmacological Agents
Pharmacol. Rev., March 1, 2001; 53(1): 73 - 92.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Brasel, T. De Smedt, J. L. Smith, and C. R. Maliszewski
Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures
Blood, November 1, 2000; 96(9): 3029 - 3039.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. J. Small, D. M. Reese, B. Um, S. Whisenant, S. C. Dixon, and W. D. Figg
Therapy of Advanced Prostate Cancer with Granulocyte Macrophage Colony-stimulating Factor
Clin. Cancer Res., July 1, 1999; 5(7): 1738 - 1744.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. V. Tjurmin, N. M. Ananyeva, E. P. Smith, Y. Gao, M. K. Hong, M. B. Leon, and C. C. Haudenschild
Studies on the Histogenesis of Myxomatous Tissue of Human Coronary Lesions
Arterioscler. Thromb. Vasc. Biol., January 1, 1999; 19(1): 83 - 97.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Santiago-Schwarz, M. McCarthy, J. Tucci, and S. E. Carsons
Neutralization of Tumor Necrosis Factor Activity Shortly After the Onset of Dendritic Cell Hematopoiesis Reveals a Novel Mechanism for the Selective Expansion of the CD14-Dependent Dendritic Cell Pathway
Blood, August 1, 1998; 92(3): 745 - 755.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. M. Page, E. M. Roberts, J. J. Peschon, and S. M. Hedrick
TNF Receptor-Deficient Mice Reveal Striking Differences Between Several Models of Thymocyte Negative Selection
J. Immunol., January 1, 1998; 160(1): 120 - 133.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
G. Grouard, M.-C. Rissoan, L. Filgueira, I. Durand, J. Banchereau, and Y.-J. Liu
The Enigmatic Plasmacytoid T Cells Develop into Dendritic Cells with Interleukin (IL)-3 and CD40-Ligand
J. Exp. Med., March 17, 1997; 185(6): 1101 - 1112.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.peprotech.com/
Copyright © 1996 by AlphaMed Press.